Short and Mid‐Term Predictors of Response to OnabotulinumtoxinA: Real‐Life Experience Observational Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Short and Mid‐Term Predictors of Response to OnabotulinumtoxinA: Real‐Life Experience Observational Study
Authors
Keywords
-
Journal
HEADACHE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-02-22
DOI
10.1111/head.13765
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety
- (2019) Andrew M Blumenfeld et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Early efficacy and late gain in chronic and high‐frequency episodic migraine with onabotulinumtoxinA
- (2019) A. Alpuente et al. EUROPEAN JOURNAL OF NEUROLOGY
- Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
- (2018) Andrew M. Blumenfeld et al. JOURNAL OF HEADACHE AND PAIN
- OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort
- (2018) Francesca Schiano di Cola et al. NEUROLOGICAL SCIENCES
- OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience
- (2018) Fabrizio Vernieri et al. NEUROLOGICAL SCIENCES
- OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study
- (2017) C. Domínguez et al. EUROPEAN JOURNAL OF NEUROLOGY
- CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study
- (2017) Clara Domínguez et al. HEADACHE
- Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data
- (2017) Brendan Davies et al. JOURNAL OF HEADACHE AND PAIN
- Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers
- (2017) Cristina Tassorelli et al. JOURNAL OF HEADACHE AND PAIN
- Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting
- (2017) Antonio Santoro et al. NEUROLOGICAL SCIENCES
- When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month
- (2016) M Torres-Ferrús et al. CEPHALALGIA
- Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
- (2016) David W. Dodick et al. HEADACHE
- Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year
- (2016) I. Aicua-Rapun et al. JOURNAL OF HEADACHE AND PAIN
- Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
- (2016) Katja Kollewe et al. JOURNAL OF NEURAL TRANSMISSION
- Factors associated with favorable outcome in botulinum toxin A treatment for chronic migraine: A clinic-based prospective study
- (2016) Mi Ji Lee et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The use of onabotulinum toxin A (Botox®) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study
- (2016) Marco Russo et al. NEUROLOGICAL SCIENCES
- Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?
- (2014) Eva Cernuda-Morollón et al. CEPHALALGIA
- Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
- (2014) H.-C. Diener et al. EUROPEAN JOURNAL OF NEUROLOGY
- CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine
- (2014) Eva Cernuda-Morollón et al. HEADACHE
- Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
- (2014) Modar Khalil et al. JOURNAL OF HEADACHE AND PAIN
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- An Exploratory Study of Salivary Calcitonin Gene-Related Peptide Levels Relative to Acute Interventions and Preventative Treatment With OnabotulinumtoxinA in Chronic Migraine
- (2013) Roger Cady et al. HEADACHE
- Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: A retrospective study
- (2013) Kuan-Hsiang Lin et al. Journal of the Chinese Medical Association
- Headache Direction and Aura Predict Migraine Responsiveness to Rimabotulinumtoxin B
- (2012) Patrick M. Grogan et al. HEADACHE
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine
- (2010) Min Yang et al. CEPHALALGIA
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- Global prevalence of chronic migraine: A systematic review
- (2009) JL Natoli et al. CEPHALALGIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started